Does TEMOZOLOMIDE Cause Diffuse large b-cell lymphoma recurrent? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with TEMOZOLOMIDE (TEMOZOLOMIDE). This represents 0.2% of all adverse event reports for TEMOZOLOMIDE.
36
Reports of Diffuse large b-cell lymphoma recurrent with TEMOZOLOMIDE
0.2%
of all TEMOZOLOMIDE reports
30
Deaths
0
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From TEMOZOLOMIDE?
Of the 36 reports, 30 (83.3%) resulted in death.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEMOZOLOMIDE. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does TEMOZOLOMIDE Cause?
Disease progression (1,562)
Death (1,403)
Off label use (1,357)
Product use in unapproved indication (1,353)
Thrombocytopenia (1,300)
Drug ineffective (1,131)
Nausea (1,071)
Neutropenia (809)
Malignant neoplasm progression (779)
Fatigue (766)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which TEMOZOLOMIDE Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
TEMOZOLOMIDE vs TEMSIROLIMUS
TEMOZOLOMIDE vs TENAMFETAMINE
TEMOZOLOMIDE vs TENAPANOR
TEMOZOLOMIDE vs TENECTEPLASE
TEMOZOLOMIDE vs TENELIGLIPTIN